Flavia Ejzykowicz

2.6k citations
31 papers · 2k · 2 hit papers · h-index 10

Impact in

    • Renal cell carcinoma treatment
    • Lung Cancer Treatments and Mutations
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer survivorship and care
    • Inflammatory Biomarkers in Disease Prognosis

Papers in

Flavia Ejzykowicz

28 papers receiving 1.9k citations

Flavia Ejzykowicz's Hit Papers

Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma 2022 · 212 citations
2120+1+3Years since publication4008001.2k

Peers

Flavia Ejzykowicz
Comparison fields: 5 of 63
  • Pulmonary and Respiratory Medicine 1.2k
  • Oncology 589
  • Endocrinology, Diabetes and Metabolism 115
  • Economics and Econometrics 142
  • Cancer Research 36
Replace Javier Martínez‐Trufero with:
Javier Martínez‐Trufero Spain
Lea Dutta United States
Vadim Viktorovich Kozlov Russia
Jerry Tan Chun Bing United States
Michelle Denise Hackshaw United States
Alketa Hamzaj Italy
Larisa Bolotina Russia
Albrecht Kretzschmar Germany
Douglas Adkins United States
Flavia Ejzykowicz relative to Javier Martínez‐Trufero Spain Javier Martínez‐Trufero's profile →
Citations per field
00.5×2×4×6.5×
Javier Martínez‐Trufero · 1×
Citations per year

Countries citing papers authored by Flavia Ejzykowicz

Since Specialization
Citations

This map shows the geographic impact of Flavia Ejzykowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavia Ejzykowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavia Ejzykowicz more than expected).

Fields of papers citing papers by Flavia Ejzykowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavia Ejzykowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavia Ejzykowicz. The network helps show where Flavia Ejzykowicz may publish in the future.

Co-authors

The 25 scholars most cited alongside Flavia Ejzykowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Flavia Ejzykowicz Line = papers co-authored together Flavia Ejzykowicz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Hit paper breakdown →
20211355
2
Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
Hit paper breakdown →
2022212
3 201677
4 202272
5 201964
6 201953
7 202437
8 201921
9 201714
10 201513
11 20137
12 20187
13 20185
14 20235
15 20245
16 20204
17 20244
18 20233
19 20222
20 20151

About Flavia Ejzykowicz

Flavia Ejzykowicz is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Statistics and Probability, Oncology and Statistics, Probability and Uncertainty, having authored 31 papers that have together received 2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Diabetes Treatment and Management (6 papers), Statistical Methods in Clinical Trials (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cutaneous Melanoma Detection and Management (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Meta-analysis and systematic reviews (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (589 citations), Endocrinology, Diabetes and Metabolism (115 citations), Economics and Econometrics (142 citations) and Cancer Research (36 citations). Flavia Ejzykowicz has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Thomas A. Burke, Josephine Louella Feliciano, Ralph P. Insinga, David J. Vanness, Swapnil N. Rajpathak, Kristel Vandormael, Sory Traore, Alex Milinovich, Changhong Yu and Kevin M. Pantalone. Their work appears in journals such as Annals of Oncology, Value in Health, Journal of Medical Economics, Clinical Therapeutics and The Science of Diabetes Self-Management and Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact